WANY
VSTM icon

Wealthspire Advisors (New York)’s Verastem VSTM Stock Holding History

Wealthspire Advisors (New York)’s Portfolio VSTM Stock Details VSTM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-20
Closed -$177 – 2861
2025
Q3 		$177 Buy
+20
New +$149 ﹤0.01% 2950

Other funds holding VSTM

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $28.2B AUM 115.26% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
FCMV
Foresite Capital Management VI Larkspur, California $460M AUM 261.77% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return

Wealthspire Advisors (New York)'s VSTM Position: Q4 2025 in Review

Wealthspire Advisors (New York) sold out of Verastem (VSTM) in Q4 2025, closing a stake of 20 shares — an estimated $177 sold.

Wealthspire Advisors (New York) first reported a position in VSTM in Q3 2025 and held it in 1 quarter. The position peaked at $177 in Q3 2025. 142 funds tracked by Wall St. Rank hold VSTM as of Q4 2025.

  • Wealthspire Advisors (New York) reported no remaining Verastem position as of Q4 2025 after selling out during the quarter.
  • Wealthspire Advisors (New York) sold 20 Verastem shares in Q4 2025, an estimated $177.
  • Wealthspire Advisors (New York) first reported a position in Verastem in Q3 2025 and held it in 1 quarter.
  • Wealthspire Advisors (New York)'s Verastem position peaked at $177 in Q3 2025.
  • 142 funds tracked by Wall St. Rank held Verastem as of Q4 2025.

Based on Wealthspire Advisors (New York)'s 13F filing for Q4 2025, filed 13 Feb 2026.